scispace - formally typeset
S

Sabine Schmitt

Researcher at Technische Universität München

Publications -  36
Citations -  1954

Sabine Schmitt is an academic researcher from Technische Universität München. The author has contributed to research in topics: Mitochondrion & Medicine. The author has an hindex of 16, co-authored 27 publications receiving 1172 citations. Previous affiliations of Sabine Schmitt include Helmholtz Zentrum München & Protein Sciences.

Papers
More filters
Journal ArticleDOI

A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol

TL;DR: Haploid genetic screening of cells under different types of mitochondrial perturbation shows that a pathway involving OMA1, DELE1 and the eIF2α kinase HRI communicates mitochondrial stress to the cytosol to trigger the integrated stress response.
Journal ArticleDOI

Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease

TL;DR: It is suggested that the mitochondrion constitutes a pivotal target of copper in Wilson disease, and copper-chelating agents reversed mitochondrial accumulation of copper, as well as signs of intra-mitochondrial membrane crosslinking, thereby preserving the functional and structural integrity of mitochondria.
Journal ArticleDOI

Regulatory myeloid cells paralyze T cells through cell-cell transfer of the metabolite methylglyoxal.

TL;DR: It is reported that human MDSCs were characterized by strongly reduced metabolism and conferred this compromised metabolic state to CD8 + T cells, thereby paralyzing their effector functions and identifying the dicarbonyl methylglyoxal as a marker metabolite for MDSC that mediates T cell paralysis and can serve as a target to improve cancer immune therapy.
Journal ArticleDOI

Methanobactin reverses acute liver failure in a rat model of Wilson disease

TL;DR: It is demonstrated that ATP7B-deficient rats recapitulate WD-associated phenotypes, including hepatic copper accumulation, liver damage, and mitochondrial impairment, and methanobactin treatment prevented hepatocyte death, subsequent liver failure, and death in the rodent model, suggesting that MB has potential as a therapeutic agent for the treatment of acute Wilson disease.